These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22905105)

  • 1. Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.
    Faustman DL; Wang L; Okubo Y; Burger D; Ban L; Man G; Zheng H; Schoenfeld D; Pompei R; Avruch J; Nathan DM
    PLoS One; 2012; 7(8):e41756. PubMed ID: 22905105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF, TNF inducers, and TNFR2 agonists: A new path to type 1 diabetes treatment.
    Faustman DL
    Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28843039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study.
    Allen HF; Klingensmith GJ; Jensen P; Simoes E; Hayward A; Chase HP
    Diabetes Care; 1999 Oct; 22(10):1703-7. PubMed ID: 10526739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration.
    Ayoub BM; Ramadan E; Ashoush N; Tadros MM; Hendy MS; Elmazar MM; Mousa SA
    Pharmazie; 2020 Aug; 75(8):375-380. PubMed ID: 32758336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.
    Wherrett DK; Bundy B; Becker DJ; DiMeglio LA; Gitelman SE; Goland R; Gottlieb PA; Greenbaum CJ; Herold KC; Marks JB; Monzavi R; Moran A; Orban T; Palmer JP; Raskin P; Rodriguez H; Schatz D; Wilson DM; Krischer JP; Skyler JS;
    Lancet; 2011 Jul; 378(9788):319-27. PubMed ID: 21714999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes.
    Keymeulen B; van Maurik A; Inman D; Oliveira J; McLaughlin R; Gittelman RM; Roep BO; Gillard P; Hilbrands R; Gorus F; Mathieu C; Van de Velde U; Wisniacki N; Napolitano A
    Diabetologia; 2021 Feb; 64(2):313-324. PubMed ID: 33145642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.
    Forlenza GP; McVean J; Beck RW; Bauza C; Bailey R; Buckingham B; DiMeglio LA; Sherr JL; Clements M; Neyman A; Evans-Molina C; Sims EK; Messer LH; Ekhlaspour L; McDonough R; Van Name M; Rojas D; Beasley S; DuBose S; Kollman C; Moran A;
    JAMA; 2023 Mar; 329(12):990-999. PubMed ID: 36826844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bacille Calmette-Guérin vaccination on C-peptide secretion in children newly diagnosed with IDDM.
    Elliott JF; Marlin KL; Couch RM
    Diabetes Care; 1998 Oct; 21(10):1691-3. PubMed ID: 9773732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GAD treatment and insulin secretion in recent-onset type 1 diabetes.
    Ludvigsson J; Faresjö M; Hjorth M; Axelsson S; Chéramy M; Pihl M; Vaarala O; Forsander G; Ivarsson S; Johansson C; Lindh A; Nilsson NO; Aman J; Ortqvist E; Zerhouni P; Casas R
    N Engl J Med; 2008 Oct; 359(18):1909-20. PubMed ID: 18843118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD
    Tavira B; Cheramy M; Axelsson S; Åkerman L; Ludvigsson J; Casas R
    Diabetologia; 2017 Jul; 60(7):1276-1283. PubMed ID: 28357504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells.
    Zhao Y; Jiang Z; Zhao T; Ye M; Hu C; Yin Z; Li H; Zhang Y; Diao Y; Li Y; Chen Y; Sun X; Fisk MB; Skidgel R; Holterman M; Prabhakar B; Mazzone T
    BMC Med; 2012 Jan; 10():3. PubMed ID: 22233865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gamma aminobutyric acid (GABA) or GABA with glutamic acid decarboxylase (GAD) on the progression of type 1 diabetes mellitus in children: Trial design and methodology.
    Choat HM; Martin A; Mick GJ; Heath KE; Tse HM; McGwin G; McCormick KL
    Contemp Clin Trials; 2019 Jul; 82():93-100. PubMed ID: 31229619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study.
    Rosenzwajg M; Salet R; Lorenzon R; Tchitchek N; Roux A; Bernard C; Carel JC; Storey C; Polak M; Beltrand J; Amouyal C; Hartemann A; Corbeau P; Vicaut E; Bibal C; Bougnères P; Tran TA; Klatzmann D
    Diabetologia; 2020 Sep; 63(9):1808-1821. PubMed ID: 32607749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamic acid decarboxylase autoantibody-positivity post-partum is associated with impaired β-cell function in women with gestational diabetes mellitus.
    Lundberg TP; Højlund K; Snogdal LS; Jensen DM
    Diabet Med; 2015 Feb; 32(2):198-205. PubMed ID: 25345799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes.
    Boettler T; Pagni PP; Jaffe R; Cheng Y; Zerhouni P; von Herrath M
    J Autoimmun; 2013 Aug; 44():40-8. PubMed ID: 23770292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation.
    Keefe RC; Takahashi H; Tran L; Nelson K; Ng N; Kühtreiber WM; Faustman DL
    Sci Rep; 2021 Jul; 11(1):14933. PubMed ID: 34294806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Effects of BCG Vaccination on Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Chang YC; Lin CJ; Hsiao YH; Chang YH; Liu SJ; Hsu HY
    J Diabetes Res; 2020; 2020():8954125. PubMed ID: 32309449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood.
    Corsenac P; Parent MÉ; Mansaray H; Benedetti A; Richard H; Stäger S; Rousseau MC
    Diabetes Metab; 2022 May; 48(3):101337. PubMed ID: 35245655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.